Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “molecular”

183 pharma patents match "molecular" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 183
Index total 30,257
Page 1 / 8

Quick answer

This filtered view shows 183 pharmaceutical patents matching "molecular" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

183 results for “molecular” · 30,257 patents in full index Clear search

  1. US 12414968

    Compositions comprising bacterially derived minicells and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  2. US 12378245

    Crystalline forms of an RSK inhibitor

    PHOENIX MOLECULAR DESIGNS · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  3. US 12357687

    Compositions and vaccines for treating and/or preventing viral infections, and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  4. US 12337033

    Encapsulated glycolipid antigens for treatment of neoplastic diseases

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  5. US 12291058

    Dispersions for additive manufacturing comprising discrete carbon nanotubes

    MOLECULAR REBAR DESIGN, LLC · Granted May 6, 2025 · Expires May 1, 2045

    granted
  6. US 12233135

    Therapeutic constructs for treating cancer

    PRECISION MOLECULAR INC. · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  7. US 12195620

    Controlled entrapment and release of molecular cargo

    The Regents of the University of California · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  8. US 12168718

    Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel

    Julius-Maximilians-Universitat Wurzburg · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  9. US 12076330

    Inhibition of lipofuscin aggregation by molecular tweezers

    The Regents of the University of California · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  10. US 12070444

    Modulation of molecular markers using S-equol

    The Board of Regents of the University of Texas System · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  11. US 11964021

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  12. US 11939379

    Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies

    The Regents of the University of California · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  13. US 11891638

    Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

    Northwestern University · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  14. US 11840704

    Adeno-associated virus variant capsids and methods of use thereof

    4D MOLECULAR THERAPEUTICS INC. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  15. US 11807868

    Adeno-associated variants, formulations and methods for pulmonary delivery

    4D MOLECULAR THERAPEUTICS INC. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted
  16. US 11801229

    Molecular entrapment via homopolymer self-assembly

    Northwestern University · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  17. US 11780904

    Method of producing recombinant high molecular weight vWF in cell culture

    Takeda Pharmaceutical Company Limited · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted
  18. US 11766487

    Treatments for retinal disease

    4D MOLECULAR THERAPEUTICS INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted
  19. US 11766489

    Adeno-associated virus variant capsids and use for inhibiting angiogenesis

    4D MOLECULAR THERAPEUTICS INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted
  20. US 11731986

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  21. US 2023203129

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    BRACCO IMAGING SPA [IT] · Granted Jun 29, 2023 · Expires Jun 24, 2043

    granted
  22. US 11628229

    Method of synthesizing 18F radiolabeled biomolecular agents

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted
  23. US 11576983

    Treatments for retinal disease

    4D MOLECULAR THERAPEUTICS INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  24. US 2023040008

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    BRACCO IMAGING SPA [IT] · Granted Feb 9, 2023 · Expires Feb 4, 2043

    granted